These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24898156)

  • 1. The role of bile acids in functional GI disorders.
    Appleby RN; Walters JR
    Neurogastroenterol Motil; 2014 Aug; 26(8):1057-69. PubMed ID: 24898156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
    Walters JR; Johnston IM; Nolan JD; Vassie C; Pruzanski ME; Shapiro DA
    Aliment Pharmacol Ther; 2015 Jan; 41(1):54-64. PubMed ID: 25329562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
    Hvas CL; Ott P; Paine P; Lal S; Jørgensen SP; Dahlerup JF
    World J Gastroenterol; 2018 Jun; 24(21):2320-2326. PubMed ID: 29881241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
    Walters JR
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):561-7. PubMed ID: 20932141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of bile acids in the pathogenesis of chronic diarrhea].
    Krums LM; Gubina AV; Parfenov AI; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2012; (3):35-9. PubMed ID: 22830222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
    Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation.
    Nakajima A; Ishizaki S; Matsuda K; Kurosu S; Taniguchi S; Gillberg PG; Mattsson JP; Hasunuma T; Camilleri M
    J Gastroenterol Hepatol; 2022 May; 37(5):883-890. PubMed ID: 35168298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the pathophysiology, diagnosis and management of chronic diarrhoea from bile acid malabsorption: a systematic review.
    Di Ciaula A; Khalil M; Baffy G; Portincasa P
    Eur J Intern Med; 2024 Oct; 128():10-19. PubMed ID: 39069430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Farnesoid X Receptor: Good for BAD.
    Keely SJ; Walters JR
    Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):725-732. PubMed ID: 28174746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Bile Acids in Chronic Diarrhea.
    Camilleri M; Vijayvargiya P
    Am J Gastroenterol; 2020 Oct; 115(10):1596-1603. PubMed ID: 32558690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid disease: the emerging epidemic.
    Oduyebo I; Camilleri M
    Curr Opin Gastroenterol; 2017 May; 33(3):189-195. PubMed ID: 28169840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases.
    Malhi H; Camilleri M
    Curr Opin Pharmacol; 2017 Dec; 37():80-86. PubMed ID: 29102744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
    Lyutakov I; Lozanov V; Sugareva P; Valkov H; Penchev P
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):380-387. PubMed ID: 33177381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elobixibat for the treatment of constipation.
    Chedid V; Vijayvargiya P; Camilleri M
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):951-960. PubMed ID: 30204504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile Acid diarrhea: prevalence, pathogenesis, and therapy.
    Camilleri M
    Gut Liver; 2015 May; 9(3):332-9. PubMed ID: 25918262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of bile acid transport alters plasma lipids and GLP-1.
    Rudling M; Camilleri M; Graffner H; Holst JJ; Rikner L
    BMC Cardiovasc Disord; 2015 Jul; 15():75. PubMed ID: 26197999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota.
    Misawa N; Higurashi T; Takatsu T; Iwaki M; Kobayashi T; Yoshihara T; Ashikari K; Kessoku T; Fuyuki A; Matsuura T; Ohkubo H; Usuda H; Wada K; Naritaka N; Takei H; Nittono H; Matsumoto M; Honda A; Nakajima A; Camilleri M
    Aliment Pharmacol Ther; 2020 Sep; 52(5):821-828. PubMed ID: 32687674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids and FXR in functional gastrointestinal disorders.
    Mosińska P; Szczepaniak A; Fichna J
    Dig Liver Dis; 2018 Aug; 50(8):795-803. PubMed ID: 29908754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acid Diarrhea: From Molecular Mechanisms to Clinical Diagnosis and Treatment in the Era of Precision Medicine.
    Yang D; Lyu C; He K; Pang K; Guo Z; Wu D
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile Acid Diarrhea in Adults and Adolescents.
    Camilleri M; Nurko S
    Neurogastroenterol Motil; 2022 Apr; 34(4):e14287. PubMed ID: 34751982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.